临床试验-金年会金字招牌信誉至上医药集团

临床试验

Clinical trial

Study Title	Conditions	Interventions	Locations
A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies2	Relapsed/Refractory B-Cell Malignancies	Drug: HSK29116	One Clinical Research Perth, Australia Woden Dermatology Phillip, Australia NANFANG Hospital Guangzhou, Guangdong, China (and 3 more...)